Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets

NCT02096458 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease
Erosive Esophagitis
Heartburn

Interventions

DRUG: Dexlansoprazole

Sponsor

Takeda